Advertisement

Journal of Anesthesia

, Volume 11, Issue 2, pp 150–152 | Cite as

Sevoflurane-induced sensitivity of neuromuscular function in a patient with myasthenia gravis in true remission

  • Junzo Takeda
  • Yuki Ohnishi
  • Toshiya Koitabashi
  • Kazuaki Fukushima
Clinical Reports

Key words

Inhalational anesthetics Sevollurane Myasthenia gravis Remission Neuromuscular monitoring 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brown JC, Charlton JE (1975) A study of sensitivity to curare in myasthenic disorders using a regional technique. J Neurol Neurosurg Psychiatr 38:27–33PubMedCrossRefGoogle Scholar
  2. 2.
    Lake CL (1978) Curare sensitivity in steroid-treated myasthenia gravis: A case report. Anesth Analg 57:132–134.PubMedGoogle Scholar
  3. 3.
    Lumb AB, Calder I (1989) Cured myasthenia gravis and neuromuscular blockade. Anaesthesia 44:828–830PubMedGoogle Scholar
  4. 4.
    Eisenkraft JB, Sawhney RK, Papatestas AE (1986) Vecuronium in the myasthenic patient (letter). Anaesthesia 41:666–667PubMedGoogle Scholar
  5. 5.
    Fillmore RB, Herren AL, Pirlo AF (1978) Curare sensitivity in myasthenia gravis (letter). Anesth Analg 57:515–516PubMedCrossRefGoogle Scholar
  6. 6.
    Abel M, Eisenkraft JB, Patel N (1991) Response to suxame-thonium in myasthenic patient during remission. Anaesthesia 46:30–32PubMedGoogle Scholar
  7. 7.
    Foldes FF, MaNall PG (1962) Myasthenia gravis: A guide for anesthesiologists. Anesthesiology 23:837–872PubMedGoogle Scholar
  8. 8.
    Rowbottom SJ (1989) Isoflurane for thymectomy in myasthenia gravis. Anaesth Intens Care 17:444–447Google Scholar
  9. 9.
    O'Flaherty D, Pennant JH, Rao K, Giesecke AH (1992) Total intravenous anesthesia with propofol for transsternal thymectomy in myasthenia gravis. J Clin Anesth 4:241–244PubMedCrossRefGoogle Scholar
  10. 10.
    Nilsson E, Paloheimo M, Muller K, Heinonen J (1989) Halothane-induced variability in the neuromuscular transmission of patients with myasthenia gravis. Acta Anaesthesiol Scand 33:395–401PubMedGoogle Scholar
  11. 11.
    Nilsson E, Muller K (1990) Neuromuscular effects of isoflurane in patients with myasthenia gravis. Acta Anaesthesiol Scand 34:126–131PubMedGoogle Scholar
  12. 12.
    Itagaki T, Tai K, Katsumata N, Suzuki H (1988) Potentiation with sevoflurane of neuromuscular blocking effects of vecuronium and pancuronium. Masui (Jpn J Anesthesiol) 37:943–954PubMedGoogle Scholar
  13. 13.
    Miller RD, Eger EI, Way WL, Stevens WC, Dolan WM (1971) Comparative neuromuscular effects of forane and halothane alone and in combination with d-tubocurarine in man. Anesthesiology 35:38–42PubMedCrossRefGoogle Scholar
  14. 14.
    Takeda J, Izawa H, Ochiai R, Fukushima K (1993) Suppression of neuromuscular transmission by sevoflurane in patients with myasthenia gravis. Anesthesiology 79:A960Google Scholar
  15. 15.
    Pirskanen R, Tiilikainen A, Hokkanen E (1972) Myasthenia gravis and HL-A antigens. Ann Clin Res 4:304–306PubMedGoogle Scholar

Copyright information

© JSA 1997

Authors and Affiliations

  • Junzo Takeda
    • 1
  • Yuki Ohnishi
    • 1
  • Toshiya Koitabashi
    • 1
  • Kazuaki Fukushima
    • 1
  1. 1.Department of Anesthesiology, School of MedicineKeio UniversityTokyoJapan

Personalised recommendations